Peter Murphy
7PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 02, 2026
What is the Value of Developing an HTA Process?Peter Murphy, Simon Walker, Septiara Putri
|Feb 18, 2026
Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?Peter Murphy, Susan Griffin, Simon Walker
|Dec 23, 2025
Costs and benefits of early access to new cancer drugs through the US Food and Drug Administration's accelerated approval pathway: retrospective observational study and economic evaluation.Huseyin Naci, Mahnum Shahzad, Peter Murphy
|Jul 14, 2025
Reflecting Social Values in HTA Methods: A Case Study of South Africa.Peter Murphy, Celeste Holden, Yirui Qian
|May 23, 2025
Are Economic Evaluations of Task Shifting Too Narrow in Focus? A Rapid Review.Peter Murphy, Susan Griffin, Helen Fulbright
|Jan 06, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.Peter Murphy, David Glynn, Sofia Dias
Pageof 2
Frequent Collaborators
2 joint publications
Sofia Dias
1 joint publications
Matthew Walton
1 joint publications
David Glynn
1 joint publications
Robert Hodgson
1 joint publications
Lindsay Claxton
1 joint publications
Lucy Beresford
1 joint publications
Katy Cooper
1 joint publications
Paul Tappenden
1 joint publications
Kate Ennis
1 joint publications
Alessandro Grosso
